Meg Rivers is the former senior editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International.
Determining Shelf Life: Reading the Stability Testing Data
Although stability testing programs for small-molecule drugs and biologics are often perceived as similar, stability programs for biologics are far more complex.
In Vivo Falls Behind In Vitro for Adventitious Agent Testing
Alternatives to animal testing and in-vivo assays are occurring as a result of recent scientific advances.
The Real Danger of Substandard and Counterfeit COVID-19 Vaccines
Low- and middle-income countries are at the greatest risk of receiving substandard and falsified COVID-19 vaccines.
Changing the Course of Drug Shortages
The COVID-19 pandemic has further impacted ongoing drug shortage issues; essential action is needed to avoid repeating previous mistakes.